Thrombus-Targeted Nanocarrier Attenuates Bleeding Complications Associated with Conventional Thrombolytic Therapy

Title
Thrombus-Targeted Nanocarrier Attenuates Bleeding Complications Associated with Conventional Thrombolytic Therapy
Authors
Keywords
localized fibrinolysis, peptide-modified-liposomes, protein delivery, targeted delivery, tissue plasminogen activator
Journal
PHARMACEUTICAL RESEARCH
Volume 30, Issue 6, Pages 1663-1676
Publisher
Springer Nature
Online
2013-03-07
DOI
10.1007/s11095-013-1011-x

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation